Cancer Biology and Precision Oncology
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Disease Biomarker".
Deadline for manuscript submissions: 20 October 2025 | Viewed by 143
Special Issue Editor
Special Issue Information
Dear Colleagues,
Advances in genetic research have revolutionized our understanding of cancer susceptibility, ushering in a transformative era for cancer biology and precision oncology. Comprehensive studies have established significant associations between single-nucleotide polymorphisms (SNPs) and the risk of various cancers, including malignancies of the brain and head and neck, lung, breast, gastrointestinal tract, urological system, gynecological organs, skin, and hematological cancers such as leukemia. These findings underscore the pivotal role of genetic variations in tumorigenesis, highlighting their potential application as molecular markers during cancer risk assessment and as therapeutic targets in precision oncology.
Despite these advances, inconsistencies persist across studies, often stemming from factors such as sample selection biases, small cohort sizes, varied methodologies, and genetic diversity among ethnic populations. These challenges underscore the urgent need for well-designed, robust studies that consolidate current knowledge and explore uncharted territory.
We welcome translational scientists to contribute original research that explores the genetic foundations of all cancer types. Submissions based solely on in silico or dry-lab analyses will not be considered. By publishing groundbreaking discoveries in the Journal of Personalized Medicine (JPM), you can aid in bridging the gap between genetic research and clinical applications. Together, we can advance our understanding of cancers and promote innovations in oncology.
Dr. Wen-Shin Chang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomarkers
- cancer genomics
- diagnosis
- single nucleotide polymorphism (SNP)
- prognosis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
